Discover Tenders by Modelling Pastes Sector

Find the most relevant tenders for Modelling Pastes. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Modelling Pastes tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Modelling Pastes tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Dexamethasone Atc Code H02Ab02 That Can Be Prescribed And Dispensed As Part Of The Consultation Hou

Deadline: 27 Jun 2026

Germany

Ref. No.: 7146194

EMD:Ref Document

Bid Value: Ref Document

83 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Propofol Atc Code N01Ax10 That Can Be Prescribed And Dispensed As Part Of The Outpatient Needs In L

Deadline: 27 Jun 2026

Germany

Ref. No.: 7145649

EMD:Ref Document

Bid Value: Ref Document

83 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7139372

EMD:Ref Document

Bid Value: Ref Document

87 Days Left

Multifunction Device And Printer Services

Deadline: 27 Jul 2027

Australia

Ref. No.: 7119193

EMD:Ref Document

Bid Value: Ref Document

478 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Evolocumab C10Ax13 Within The Framework Of A So Called Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110598

EMD:Ref Document

Bid Value: Ref Document

87 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lanthanum Iii Carbonate Chewable Tablets Only V03Ae03 Within The Framework Of A So

Deadline: 01 Jul 2026

Germany

Ref. No.: 7110380

EMD:Ref Document

Bid Value: Ref Document

87 Days Left

Wildfire General Predictive Services

Deadline: 01 Jun 2026

Canada

Ref. No.: 7105776

EMD:Ref Document

Bid Value: Ref Document

57 Days Left

Economic Fiscal And Environmental Scenario Analysis

Deadline: 31 May 2027

Canada

Ref. No.: 7104020

EMD:Ref Document

Bid Value: Ref Document

421 Days Left

Mannheim Franklin Sullivan Nord

Deadline: 01 Sep 2028

Germany

Ref. No.: 7068048

EMD:Ref Document

Bid Value: Ref Document

880 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Triptorelin Atc L02Ae04 Obo For The Period 01 09 2024 31 08 2026

Deadline: 05 Jul 2026

Germany

Ref. No.: 7066413

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Miglustat Atc Code According To Who A16Ax06

Deadline: 01 Sep 2026

Germany

Ref. No.: 7066220

EMD:Ref Document

Bid Value: Ref Document

149 Days Left

Boosting Engagement To Increase Flexibility

Deadline: 31 Aug 2026

Spain

Ref. No.: 7016925

EMD:Ref Document

Bid Value: Ref Document

148 Days Left

Health Innovation North East And North Cumbria Hi Nenc Dynamic Purchasing System Dps

Deadline: 25 May 2028

Great Britain

Ref. No.: 7006525

EMD:Ref Document

Bid Value: Ref Document

781 Days Left

Conclusion Of Non Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V Open House Model

Deadline: 01 Jul 2026

Germany

Ref. No.: 6956974

EMD:Ref Document

Bid Value: Ref Document

87 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Rivaroxaban Atc B01Af01 In The Active Strength 2 5 Mg Per Divided Oral Dosage Form

Deadline: 27 Jun 2026

Germany

Ref. No.: 6914003

EMD:Ref Document

Bid Value: Ref Document

83 Days Left

Showing 9121 to 9135 of 9340 results

Discover Tenders by Modelling Pastes Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Modelling Pastes Sector

Filter Your Search

FREE Trial plan for all new users!